Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5355_Библиотеки_им_академика_М_И_Перельмана
.pdf
https://t.me/med1917
newgenrtpdf
224
Handbook of 3D Printing in Pharmaceutics
FIGURE 12.2 Personalized medical devices’ decision tree regulatory overview. (Personalized medical devices including
3D Printing TGA V5. 1. August 2022.)
https://t.me/med1917
TABLE 12.8
Regulatory Overview of 3D Printing in US, EU, and Australia
US EU Australia
Regulatory Agency CDER (USFDA) EMA TGA
Classication Class III Class III Class III
Law/ directive Included under Additive Manufactured
Medical Devices
Design input Patient matched device designed using
patient medical image
Functional
Operative qualication Operational qualication (as per the
requirements
Performance
requirements
Design process
Additive Manufacturing and Hot Isostatic
Process
Standard development with documentation Not applicable Not applicable
and output
Authentication and
non- disruptive assessments/ Quality Non- destructive evaluations/ Quality Safety, performance and Clarication/
validation
Regulatory
perspective
Intellectual Property, bureaucratic
distribution, premarket restrictions and
control
Regularity ISO/ ASTM 52915 ISO/ ASTM TC 261 - ASTM F42 -
Acceptance QMS certication CE marking QMS certication
3DP Report on crucial technology-
Personalized and 3DP devices
based products
Esthetical preferences of the patients Patient- customized device
Realistic anatomical Geometries
FDA)
Additive manufacturing Safety
Quality management System
Protecting human health and safety Regulated according to biological
framework
ISO 31485
CEN/ TC 438Digital Single Market
ECCommunications, 201
newgenrtpdf
3D-Printed Pharmaceuticals
Sources: Dodziuk et al. (2016a, b) and Wang et al. (2016).
225
https://t.me/med1917
226
Handbook of 3D Printing in Pharmaceutics
Medical device production systems (MDPS) are a novel statutory concepts exclusively meant for healthcare for customized production of patient- matched devices.
An overview of a decision tree by the regulatory authority for personalized medical
devices is represented in Figure 12.2.
12.6 CONCLUSION
At this present moment, 3DP devices are regularized similarly to the ones designed by
conventional strategies. This statuatory substructure should be applicable despite the
fact that 3DP devices are employed immediately after production, without allowing for
extended quality- control procedures. The FDA has amended the guidance documents
on 3DP. The Australian agency has already paved the way for superior regulations,
and the guidelines within the EU need to be brought up to date. The investigations
and laws of 3DP is to be fostered in the mere future. The laws on intellectual property
need to be specied and regulated to withhold offences and mistreatments for not- forprot applications. The potential of 3DP for creating customized pharmaceuticals is
undeniable; regardless of how, machine diversications are basic for proper pharmaceutical use. Furthermore, within- reach fabrication methods are worthwhile for
public safety and efcient treatment procedures, and making their path into the commercial market by collaborative actions of regulation and patent authorities should
collaborate with businesses.
REFERENCES
Applying Human Factors and Usability Engineering to Medical Devices. Guidance for
Industry and Food and Drug Administration Staff, 2016. Available from www.fda.gov/
media/ 80481/ downl oad
Aprecia Pharmaceuticals LLC, “FDA Approves the First 3D Printed Drug Product,” News
release, August 3, 2015, www.apre cia.com/ news/ fda- appro ves- the- rst- 3d- prin ted- drugprod uct
Banks J, “Adding value in additive manufacturing: Researchers in the United Kingdom
and Europe look to 3D printing for customization,” IEEE Pulse, vol. 4, pp. 22–
26, 2013.
Buanz ABM, Basit AW. Preparation of personalized- dose salbutamol sulphate oral lms with
thermal ink- jet printing. Pharm. Res., vol. 28, no. 10, pp. 2386– 2392, 2011.
Buanz ABM, Gaisford S, Basit AW, “Preparation of personalized- dose salbutamol sulphate
oral lms with thermal ink- jet printing,” Pharm. Res., vol. 28, no. 10, p. 2386, 2011.
Centre for Medical Device Evaluation, National Medical Products Administration, People’s
Republic of China, “Guidelines for the Technical Review of Custom Additive
Manufacturing Medical Device Registration,” February 26, 2018. www.cmde.org.cn/
CL0 063/ 6954.html
Centre for Medical Device Evaluation, National Medical Products Administration, People’s
Republic of China, “3D printing articial vertebrae registration technical review
guidelines (No. 36 of 2020),” June 5, 2020. www.cmde.org.cn/ CL0 112/ 21043.html
https://t.me/med1917
3D-Printed Pharmaceuticals
Centre for Medical Device Evaluation, National Medical Products Administration, People’s
227
Republic of China, “3D printed acetabular cup product registration technical review
guidelines (No. 36 of 2020),” June 5, 2020. www.cmde.org.cn/ CL0 112/ 21042.html
Dodziuk H. Applications of 3D printing in healthcare. Kardiochir Torakochirurgia Pol, vol. 13,
no. 3, pp. 283– 293, 2016a. https:// doi.org/ 0. 5114/ kitp. 2016.62625
Dodziuk H. The Bridge Fix mechanism: An innovative foot and ankle joint fusion system util-
izing 3D printing and OsseoTi® porous metal technology. J. Ortho. Innov., vol. 9, no. 3,
pp. 123– 130, 2016b.
Fina F, Goyanes A, Gaisford S, Basit AW, “Selective laser sintering (SLS) 3D printing of
medicines,” Int. J. Pharm., vol. 529, pp. 285– 293, 2017.
Gallagher MB, “3 Questions: The Risks of Using 3D Printing to Make Personal Protective
Equipment,” Massachusetts Institute of Technology, March 26, 2020, https:// news.mit.
edu/ 2020/ 3q- risks- using- 3d- print ing- make- perso nal- pro tect ive- equipm ent- 0326
General Electric, “The FAA cleared the rst 3D printed part to y in a commercial jet engine
from GE,” April 14, 2015. www.ge.com/ news/ repo rts/ the- faa- clea red- the- rst- 3d- prin
ted- part- to- y- 2
Goyanes A, Det- Amornrat U, “3D scanning and 3D printing as innovative technologies for
fabricating personalized topical drug delivery systems,” J. Control. Release, vol. 234,
pp. 41– 48, 2016.
Goyanes A, Martínez- Pacheco R, Basit AW, “Fused- lament 3D printing of drug
products: Microstructure analysis and drug release characteristics of PVA- based caplets,”
Int. J. Pharm., vol. 234, pp. 290– 295, 2016.
Guide to application of the Machinery Directive 2006/ 42/ EC - Edition 2.2. Available from
https:// osha.eur opa.eu/ en/ legi slat ion/ gui deli nes/ guide- appl icat ion- machin ery- direct ive20064 2ec
H.R.7115 – 3- D Firearms Prohibitions Act, 115th Congress, 2017– 2018, www.congr ess.
gov/ bill/ 115th- congr ess/ house- bill/ 7115/ text?r= 1&fbc lid= IwAR2ara4EL2d6RHk5M_
hNXHOKLaYlPcYm AScl _ hBg TIV0 unCw _ dk5 VPPG O4E
Hospital for Special Surgery, “First Surgeries Completed With Patient- Specic 3D Printed
Implants Produced at the LimaCorporate ProMade Point- of- care Center at Hospital for
Special Surgery,” News release, March 8, 2022, https:// news.hss.edu/ rst- surger iescomple ted- with- pati ent- speci c- 3d- prin ted- impla nts- produ ced- at- the- limaco rpor ate-
prom ade- point- of- care- cen ter- at- hospi tal- for- spec ial- surg ery/ .
https:// hea lth.ec.eur opa.eu/ medi cal- devi ces- sec tor/ new- regu lati ons/ cont acts _ en
Huang W, Zheng Q, Sun W, Yang X, “Levooxacin implants with predened microstructure
fabricated by three- dimensional printing technique,” Int. J. Pharm., vol. 339, pp. 33–
38, 2007.
Jacob J, Coyle N, Thomas GW, Donald CM, Henry LS, Nemichand BJ. “Rapid disperse dosage
form containing levetiracetam,” US9339489B2 (Patent), 2017.
Jamróz W, Kurek M, Szafraniec J, Syrek K, “3D printed orodispersible lms with Aripiprazole,”
Int. J. Pharm., vol. 533, no. 2, pp. 413– 420, 2017.
Katstra WE, Teung P, Rowe CW, Giritlioglu B, Cima MJ, “Oral dosage forms fabricated by
three- dimensional printing,” J. Control. Release, pp. 1– 9, 2000.
Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ, “3D Printing of tablets containing
multiple drugs with dened release proles,” Int. J. Pharm., vol. 494, no. 2, pp. 643–
650, 2015.
Markets and Markets, “3D Printing Market Worth $42.9 Billion by 2025 With a Growing
CAGR of 23.3%.” www.market sand mark ets.com/ PressR elea ses/ 3d- print ing.asp
https://t.me/med1917
228
Martin, N, “FAA Drafts Plan to Regulate Additive Manufacturing of Aerospace Components,”
Handbook of 3D Printing in Pharmaceutics
October 23, 2017. www.execu tive gov.com/ 2017/ 10/ faa- dra fts- plan- to- regul ate- addit ive-
manufa ctur ing- of- aerosp ace- com pone nts/
Martinez PR, Goyanes A, Basit AW, Gaisford S, “Fabrication of drug- loaded hydrogels
with stereolithographic 3D printing,” Int. J. Pharm., 2017, doi: 10.1016/
j.ijpharm.2017.09.003
Morey B, “Metal 3D Printing Comes to Mayo’s Engineering Division,” SME, May 20, 2020,
www.sme.org/ techn olog ies/ artic les/ 2020/ may/ metal- 3d- print ing- comes- to- mayos- engi
neer ing- divis ion/
Pardeike J, Schrödl N, Voura C, Gruber M, Khinast JG, “Nanosuspensions as advanced
printing ink for accurate dosing of poorly soluble drugs in personalized medicines,” Int.
J. Pharm., vol. 420, no. 1, pp. 93– 100, 2011.
ProMade Point- of- care Centre for Complex Orthopaedic Solutions in New York. Established
by the Hospital for Special Surgery (HSS) and Lima Corporate SPA. 2022.
Salmoria GV, Klauss P, Zepon KM, “The effects of laser energy density and particle size in the
selective laser sintering of polycaprolactone/ progesterone specimens: Morphology and
drug release,” Int. J. Adv. Manuf. Technol., vol. 66, pp. 1113– 1118, 2013.
Sandler N, Maattanen A, Ihalainen P, Kronberg L, Viitala T, “Inkjet printing of drug substances
and use of porous substrates towards individualized dosing,” J. Pharm. Sci., vol. 100,
pp. 3386– 3395, 2011. www.gov.cn/ xin wen/ 2017- 12/ 14/ cont ent_ 5246 754.htm
Scoutaris N, Alexander MR, Gellert PR, Roberts CJ, “Inkjet printing as a novel medicine for-
mulation technique,” J. Control. Release, 2011, doi: 10.1016/ j.jconrel.2011.07.033
Tracy T, Wu L, Liu X, Cheng S, Li X, “3D printing: Innovative solutions for patients and
pharmaceutical industry,” Int. J. Pharm., vol. 631, 2023.
U.S. Food and Drug Administration, “CDER Researchers Explore the Promise and Potential
of 3D Printed Pharmaceuticals,” 2017, www.fda.gov/ drugs/ news- eve nts- human- drugs/
cder- rese arch ers- expl ore- prom ise- and- potent ial- 3d- prin ted- phar mace utic als
U.S. Food and Drug Administration, “Statement by FDA Commissioner Scott Gottlieb, M.D.,
on FDA Ushering in New Era of 3D Printing of Medical Products; Provides Guidance
to Manufacturers of Medical Devices,” News release, December 4, 2017, www.fda.gov/
news- eve nts/ press- announ ceme nts/ statem ent- fda- commi ssio ner- scott- gottl ieb- md- fda-
usher ing- new- era- 3d- print ing- medi cal- produ cts
VHA Innovation Ecosystem, “3D Printing at VHA,” 2022, www.va.gov/ INNO VATI ONEC
OSYS TEM/ ass ets/ ima ges/ covid- ima ges/ 3D- Print ing- Overv iew- HIMSS _ v2.pdf
Wang J, Goyanes A, Gaisford S, Basit AW. “Stereolithographic (SLA) 3D printing of oral
modied- release dosage forms,” Int. J. Pharm., vol. 503, no. 1– 2, pp. 207– 212, 2016.
https:// doi.org/ 10. 1016/ j. ijpha rm. 2016. 03. 016
Wu BM, Borland SW, Cima LG, Sachs EM, “Solid free- form fabrication of drug delivery
devices,” J. Control. Release, vol. 40, pp. 77– 87, 1996.
Wu W, Zheng Q, Liu Y, Sun J, “A programmed release multi- drug implant fabricated by three-
dimensional printing technology for bone tuberculosis therapy,” Biomed. Mater., vol.
4, 2009.
Zidan A et al., “Extrudability analysis of drug loaded pastes for 3D printing of modied
release tablets,” Int J Pharm, vol. 554, pp. 292– 301, 2019, https:// doi.org/ 10.1016/ j.ijph
arm.2018.11.025
Zidan A et al., “Development of mechanistic models to identify critical formulation and pro-
cess variables of pastes for 3D printing of modied release tablets,” Int J Pharm, vol.
555, pp. 109– 123, 2019, https:// doi.org/ 10.1016/ j.ijph arm.2018.11.044
https://t.me/med1917
229
Index
A
ABS, 92, 139, 181
Acceptance, 41, 42, 82, 87, 92, 95, 225
Acetone, 13, 77
Adaptability, 4, 37, 40, 52, 167, 185
Aerospace, 26, 27, 33, 34, 41, 42, 82, 194, 228
Alcohol, 9, 77, 104, 111, 112, 163, 171
Amorphous, 7, 117, 139, 147, 160, 199, 209
Antibiotic, 19, 24, 47, 81
Antimicrobial, 5, 9, 21, 22, 146
Automation, 148, 154, 155, 157, 159, 161, 163,
165, 167, 169, 171, 173, 175, 191
B
Balance, 55, 57, 58, 94, 95, 164, 183, 186, 187
Binders, 58, 106, 109, 112, 117, 129
Bioavailability, 22, 87, 88, 92, 118, 201
Biocompatible, 5, 68, 77, 83, 112, 140, 156– 160, 162
Biodegradable, 5, 8, 81, 84, 91, 96, 141, 159, 160,
166, 167, 173, 174, 180, 189, 194, 197
Biofabrication, 5, 80, 97, 99, 171, 193
Bioink, 99, 158– 160, 162, 164, 167, 170– 175
Biological, 3, 5, 23, 32, 93, 103, 106, 130, 136,
141– 144, 146– 148, 158, 160, 192, 212, 213,
225
Biomedical, 20, 21, 24, 46, 81, 98, 100, 153, 160,
165, 167, 168, 170, 174, 175
Biotechnology, 19, 79, 148, 149, 193
C
Cancer, 4, 62, 74, 76, 78– 81, 96, 99, 166
Capabilities, 9, 25, 57, 74, 126, 137, 148, 150,
159, 165
Capsules, 8, 41, 76, 80, 116, 147, 218
Carbon, 36, 44, 87, 114, 137, 188, 189, 192, 194
Cardiac, 24, 159, 166, 167, 170
Cartilage, 147, 158, 159, 164, 171– 175
Casting, 10, 25, 89, 139, 160
Catheters, 5, 9, 21, 24, 47, 156
Cellulose, 9, 12, 13, 15, 73, 76, 77, 91, 97, 105,
127, 128, 139, 143, 158, 165, 167, 172
Ceramics, 25, 32, 35, 40, 41, 56, 83, 109, 116,
126, 145, 148, 157, 171
Chemical, 78, 79, 84, 104, 107, 115, 142, 148,
149, 153, 160– 162, 164, 196, 201, 204, 205,
208, 222
Chitosan, 96, 146, 159, 160, 163, 167, 168, 170,
172, 174
Clinical, 6, 7, 19, 23, 26, 38, 44, 79, 89, 93, 97,
128, 135, 171, 195, 211, 215, 216, 223
Coating, 9, 19, 34, 41, 57, 121, 125, 138, 199
Collaboration, 55– 58, 186, 215
Collagen, 136, 141, 144, 159, 160, 164, 167, 172,
173
Combination, 8, 30, 44, 52, 61– 63, 67, 80, 89,
103, 106, 107, 111, 125, 141, 148, 165, 166,
180, 213
Commercial, 8, 33, 41, 91, 92, 96, 112, 141, 165,
166, 171, 200, 203, 212, 215, 219, 226, 227
Compatibility, 13, 53, 56, 58, 60, 90, 91, 93, 109,
121, 206
Complexity, 25, 53, 57, 58, 145, 164, 184
Compliance, 8, 37, 38, 41, 42, 52, 53, 55– 58, 92,
93, 95, 115, 116, 120, 183, 186, 203, 204, 211,
222
Component, 29, 31, 52, 74, 90, 92, 107, 109, 113,
115, 121, 144, 145, 155, 158, 182, 183, 194,
221
Composite, 36, 46, 100, 131, 160, 167, 174, 199, 208
Composition, 34, 67, 71, 90, 104, 108, 111, 113,
116, 117, 122, 160, 162, 196, 219
Comprehensive, 9, 18, 44, 56– 58, 60, 62, 83, 93,
194
Construction, 26, 32, 76, 80, 82, 94, 137, 142,
191, 203
Consumption, 40, 180, 186, 188– 190, 192– 194
Copolymer, 15, 16, 167, 173
D
Damage, 42, 199, 203
Decentralized, 89, 183, 185, 187, 216
Defects, 21, 30, 46, 59, 100, 113, 171, 199, 205, 206
Demand, 18, 41, 51, 53, 58, 59, 82, 106, 107, 184,
185, 189, 203
Demonstrated, 8, 9, 30, 38, 88, 143, 159, 166,
167, 195
Density, 12, 15, 84, 104, 106– 109, 113, 114, 116,
123– 126, 129, 130, 196, 199– 201, 210, 228
Designs, 3, 5, 25, 26, 41, 82, 87, 91, 126, 144,
154, 183, 187, 222
Destructive, 195, 197, 199, 203, 207, 210, 225
Develop, 5, 10, 37, 42, 62, 89, 92, 120, 125, 127,
130, 132, 135, 142, 155, 158, 159, 162, 164,
165, 167, 180, 184, 186, 202, 204, 213
Disintegration, 12, 13, 15, 17, 38, 75, 104, 127,
128, 155, 200, 201
Distortion, 104, 108, 113, 126, 145
229
https://t.me/med1917
230
230
Droplet, 17, 106– 9, 123– 126, 149
Drug delivery, 4– 8, 10, 11, 29, 38, 39, 43, 74, 88,
89, 91, 94, 105, 112, 137, 138, 140, 146, 166,
179, 180
Durability, 13, 103, 125, 156, 157, 199
E
Economic, 95, 177, 179– 181, 183– 187, 189– 191,
193
Effective, 43, 76, 77, 95, 114, 142, 164– 167, 202,
207, 210, 215
Elasticity, 158, 159, 163, 200
Emissions, 188– 190
Energy, 27, 33, 35, 42, 44, 46, 82, 107, 137,
188– 190, 192, 228
Enhance, 8, 11, 54, 75, 84, 96, 111, 116, 164, 188,
189, 193, 197, 207
Environment, 40, 42, 43, 55, 60, 90, 143, 164,
183, 186– 188, 191, 192, 220
Ethanol, 13, 14, 16, 105, 128, 164
Evaluation, 18, 21, 23, 24, 79, 81, 93, 118, 119,
128, 130, 148, 173, 197, 199, 204, 207, 213,
226, 227
Extensive, 4, 11, 42, 61, 77, 126, 186
Extrusion- based, 19, 54, 63, 65, 67– 69, 71, 73,
75, 77– 85, 87– 89, 91, 93, 95– 99, 120, 154,
166
F
Fabricate, 6, 22, 32, 67, 74, 114, 118, 127, 128,
153, 160, 200
Fabrication, 9, 18– 23, 25, 27, 33, 35, 36, 38, 45,
62, 67, 75, 78, 79, 81, 83– 86, 88, 90, 97– 99,
117, 118, 123, 129, 130, 132, 149, 150, 153,
156, 157, 167, 172, 174, 179, 182, 193, 194,
196, 197, 201, 211, 213, 226, 228
Factors, 18, 20, 30, 41, 52, 68, 71, 85, 87, 91, 98,
100, 106, 107, 109, 110, 121, 123– 125, 127,
130, 144, 174, 184, 196, 200, 201, 203, 206,
209, 213, 215, 226
FDM, 7– 10, 12, 14, 15, 18, 20, 22, 23, 29, 30, 34,
35, 45, 68, 69, 74, 75, 77– 79, 81, 83– 88, 90, 91,
96– 100, 135, 154– 157, 163, 168, 174, 196, 200
Feedstock, 33, 69, 72, 82, 87, 99, 118, 138, 207
Filament, 12, 29, 35, 54, 74, 78, 82, 84– 86, 90, 92,
99, 154, 155, 193, 196, 207, 209
Finished, 31, 40, 52, 57, 68, 71, 75, 104, 124, 138,
183, 186, 189, 195, 199, 204, 205, 207, 214
Flexibility, 8, 18, 39, 67, 94, 115, 137, 142, 165,
179, 184, 185, 196, 214
Floating, 15, 63, 70, 73, 80, 88
Flowability, 109, 121– 124, 129
Framework, 58, 93, 96, 112, 122, 154, 155, 167, 187,
191, 193, 194, 216, 217, 220, 221, 223, 225
Friability, 12– 17, 128, 196, 200
FTIR, 15– 17, 196, 201
Fusion, 35, 43, 83, 84, 86, 96, 104, 137, 154, 204,
219, 227
G
Gelatin, 141, 144, 158, 160, 164, 172, 173, 194
Glycol, 9, 14– 16, 63, 76, 105, 143, 144, 160, 167,
168
Glycolate, 13, 14, 16, 73, 91, 165
H
Hardness, 13– 17, 123, 128, 196, 200, 201, 208,
209
Hardware, 68, 74, 98, 154, 155, 197
Healthcare, 3– 6, 11, 18, 20, 22, 27, 37, 39– 42,
52, 53, 57, 61– 64, 82, 92, 100, 165, 180, 182,
183, 186, 190– 193, 203, 211, 216, 217, 226,
227
Heating, 30, 31, 69, 71, 72, 74, 92, 139, 204
High- quality, 59, 60, 137, 186, 207
High- resolution, 31, 55, 115, 131, 181, 199
Homogeneity, 108, 109, 122, 196, 199
Hybrid, 36, 42, 44– 46, 107, 151, 174
Hydrochlorothiazide, 12, 13, 20, 73, 75, 116, 136,
218
Hydrogel, 89, 97– 99, 141, 144, 147, 149, 159,
160, 163, 170, 172, 173, 175, 181, 218
Hydrophobicity, 156, 157, 164
Hydroxyapatite, 112, 119, 127, 130, 144, 157,
170
I
Impact, 8, 42, 51, 56, 57, 68, 71, 74, 75, 77, 79,
90, 99, 113, 115, 118, 125, 130, 131, 148, 156,
157, 179, 185– 188, 190, 193, 196, 200, 203,
206
Implant, 5, 7, 30, 77, 95, 104, 111, 162, 165, 168,
172, 218, 219, 228
Industrial, 3, 22, 25, 41, 42, 44, 62, 72, 81, 90,
116, 126, 129, 145, 146, 167, 191– 194, 223
Inll, 22, 31, 73, 196, 200, 201
Inuence, 3, 20, 38, 57, 68, 70, 84, 85, 87, 91, 92,
107, 116, 117, 123, 124, 162, 167, 200, 201,
206
Ingredients, 22, 31, 37, 38, 52, 56, 58, 62, 91, 95,
104, 136, 141, 143, 147, 183, 212
Innovation, 26, 43, 44, 52, 55– 58, 60, 63, 94, 179,
183, 186, 187, 191– 195, 206, 216, 228
Integration, 8, 22, 41, 56, 115, 149, 150, 155,
189
Investigation, 9, 18, 34, 45, 51, 52, 63, 80, 98, 113,
128, 131, 172, 189
Index
https://t.me/med1917
231
Index
K
Kinetics, 8, 9, 12, 16, 32, 55– 57, 89, 166
L
Lactose, 73, 105, 112, 118, 119, 127, 128
Layer- by- layer, 25, 29, 33, 34, 54, 55, 67, 135,
137, 140, 142, 154, 203
Low- cost, 54, 82, 84, 103, 160, 199
M
Machinability, 163
Machinery, 36, 220, 221, 227
Magnetic, 4, 116, 201
Maintenance, 7, 185, 205, 215, 221
Malleability, 163
Manufacture, 35, 37, 41, 43, 55, 74, 114, 127, 138,
143, 165, 182, 185, 187, 188, 192, 193, 195,
203, 204, 207, 216, 217, 220, 221, 223
Matrix, 77, 87, 111, 128, 131, 142, 157– 160, 162,
165, 198, 202
Measurements, 16, 26, 39, 145, 200, 203, 209
Mechanism, 69– 71, 100, 166, 167, 219, 227
Medicinal, 9, 55, 94, 114, 139, 183, 187, 205, 211
Melt, 9, 10, 14– 16, 22, 24, 27, 33, 64, 74, 90, 91,
104, 111, 118, 137, 163
Melting, 12, 14, 15, 20, 27, 29, 34, 35, 55, 67, 77,
83, 92, 117, 118, 136– 139, 142, 145, 149, 150,
154, 157, 196
Methylene, 13, 105, 112, 127, 128, 218
Microcrystalline, 13, 73, 91, 105, 127, 128
Microneedles, 10, 19, 21, 89, 114, 179
Microscopy, 12, 15, 146, 198, 199, 202, 203, 206,
208, 210
Microstructure, 20, 34, 79, 84, 97, 147, 227
Mixture, 30, 91, 104, 112, 121, 123, 124, 127,
129, 138, 158
Modelling, 19, 21– 23, 35, 45, 54, 81, 98, 130
Molecular, 10, 14, 18, 62, 78, 92, 111, 123, 150
N
Nanoparticles, 5, 96, 107, 113– 115, 171
Natural, 112, 127, 148, 158– 162, 167, 180, 186,
218
Non- destructive, 146, 149, 196– 199, 205– 210
Nozzle, 27, 29, 30, 32, 35, 54, 69– 72, 74, 82, 84,
87, 90, 92, 94, 95, 97, 98, 106, 114, 120, 123,
124, 131, 154, 168, 203
O
Obstacles, 18, 39, 41– 43, 51, 61, 128, 180, 184
On- demand, 40, 61, 180, 184, 189, 195, 203, 210,
216
Optical, 167, 172, 196, 199, 203, 208– 210
Organ, 5, 18, 21, 67, 72, 78, 97, 142, 162
Orodispersible, 8, 10, 13, 20– 22, 44, 45, 76, 117,
118, 127, 227
Orthopedic, 5, 19, 95, 96, 99, 163
Osmotic, 62, 73, 89, 116, 136
Outcomes, 3, 4, 11, 37– 39, 52, 57, 59, 61, 67, 73,
76, 78, 142, 182, 184, 190, 223
Oxidized, 158, 159, 167, 170, 172
P
Packing, 108– 110, 113, 114, 124, 129, 131, 189
Paracetamol, 8, 11– 14, 16, 17, 19, 72, 74, 79, 80,
88, 91, 116, 141, 202, 218
Parameters, 12, 14, 16, 20, 42, 45, 53, 57– 60, 63, 84,
85, 88, 90, 92, 95, 96, 100, 106, 107, 109, 113,
116, 117, 121, 123, 129, 138, 142, 146, 148, 155,
167, 168, 196, 197, 200, 207, 222, 223
Particle, 107, 109, 110, 114, 117, 121– 124, 129,
130, 137, 149, 228
Pattern, 55, 75, 87, 99, 107, 115, 137, 141, 154,
165, 201, 203, 218
Pediatric, 37– 39, 63, 88, 95, 125, 168, 194
Pellets, 8, 18, 35, 116
Performance, 36, 52, 56, 57, 100, 110, 116, 118,
130, 135, 143, 144, 155, 162, 193, 196, 203,
219, 223, 225
Pharmaceuticals, 5, 8, 18, 22, 38, 40, 41, 43, 46,
47, 51– 64, 67, 68, 72, 75, 78, 79, 83, 84, 91– 94,
96, 103, 112, 117, 118, 120, 127, 129, 136, 138,
145, 146, 153, 165, 167, 180,
182– 185, 187, 189, 191, 192, 194, 195, 197,
202, 204, 206, 208, 210– 213, 215, 217, 219,
221, 223, 225– 228
Pharmacy, 18, 22, 43, 62, 64, 81, 118, 146, 150,
190, 195, 207
Phase, 35, 57, 92, 103, 104, 113
Phosphate, 89, 104, 112, 127, 130, 132, 141, 167
Photosensitive, 31, 137
Piezoelectric, 98, 106, 107, 123, 130
Plasticity, 163
Platform, 18, 27, 29, 32, 55, 74, 75, 94, 100, 115,
116, 123, 125, 137– 139, 154, 155, 203, 210,
219
Polycaprolactone, 13, 22, 76, 77, 91, 144, 147,
158– 160, 166– 168, 171, 172, 228
Polyethylene, 9, 14– 16, 63, 92, 105, 127, 160,
167, 168
Polymers, 9, 22, 23, 25, 40, 41, 43, 45, 53, 56, 58,
62, 68, 75, 78– 84, 87, 91, 92, 94– 97, 100, 116,
127, 135– 39, 141, 143, 147– 150, 156, 158, 163,
165, 171– 174, 210
Post- processing, 26, 29, 36, 40, 42, 56– 58, 60,
104, 116, 144, 146
231
https://t.me/med1917
232
232
Preparation, 36, 45, 63, 73, 75– 77, 80, 98, 99, 103,
123, 129, 137, 147, 158, 172, 202, 207, 226
Pressure, 17, 29, 30, 68– 70, 84, 87, 89, 106, 107,
120, 153, 154, 203
Printability, 18, 23, 24, 62, 90, 111, 118, 131, 132,
148, 155, 158, 159, 162, 164, 167, 172
Product, 7, 18, 25, 39, 45, 46, 52, 55– 62, 68, 92,
93, 95, 100, 103, 104, 112– 114, 118, 119,
123– 125, 128, 135, 139, 144, 146, 159, 166,
168, 179, 183– 185, 192– 199, 201– 217, 211,
213, 215, 219– 222, 226, 227
Progress, 26, 41– 46, 60, 63, 64, 114, 117, 148,
150, 194, 202
Prominent, 5, 9, 159
Prosthetics, 5, 18, 40, 67, 190
Prototypes, 26, 39, 40, 79, 82, 103, 131, 135, 139
Prototyping, 20, 23, 25– 27, 38, 39, 43– 46, 67, 74,
75, 80, 126, 130, 135, 140, 142, 148, 174, 179,
190, 193
Q
Qualities, 34, 38, 77, 104, 110, 144, 162, 196,
200, 204
Quality- control, 55– 57, 59, 60, 186, 199, 206,
212, 226
R
Radiation, 8, 137, 154, 157, 218
Radiology, 23, 24, 47
Range, 5, 7– 9, 26, 29– 31, 39, 56, 74, 75, 77, 78,
95, 107, 113, 126, 127, 137, 140, 141, 145, 154,
165, 179, 181, 200
Rapid, 20, 23, 25, 27, 31, 43, 45, 46, 57, 62, 67,
77, 80, 85, 86, 98, 100, 103, 105, 127– 131, 135,
142, 148, 149, 165, 170, 174, 193, 199, 202,
207, 208, 210, 211, 227
Rawm, 27, 82, 123, 129, 185– 189, 195– 197, 201
Recommendationsm, 93, 97, 200, 212, 214, 215,
221
Recyclable, 40, 156, 157, 180, 189
Regenerative, 5, 18, 19, 42, 97, 163, 192
Regulation, 21, 56, 58, 61, 93, 140, 180, 214, 219,
222, 223, 226
Reinforced, 36, 44, 96, 100, 158, 170
Relationship, 104, 110, 121, 122, 155, 162, 182,
183, 197
Reproduced, 28– 30, 32– 34
Requirements, 5, 52, 57, 58, 60, 92, 94, 109, 115,
158, 180, 182, 192, 196, 199, 201, 204, 211,
213, 214, 217, 219– 221, 225
Resistance, 84, 116, 140, 142, 156, 157, 165, 222
Resolution, 4, 13, 31, 54, 55, 68, 72, 86, 89, 90,
104, 121, 124, 125, 142, 208
Restricted, 8, 42, 127, 145, 187, 199
Revolutionize, 37– 39, 51, 61, 120, 136, 165, 180,
204, 212
Rheological, 62, 84, 91, 95, 106, 158, 159, 196
Roughness, 95, 104, 125, 181, 203, 209, 210
S
Scaffolds, 5– 7, 22, 80, 87, 89, 90, 127, 129– 132,
141, 142, 144, 146, 147, 149, 157, 162,
165– 167, 171– 175
Scale, 14, 41, 142, 146, 185, 186, 189
Scanning, 6, 12, 15, 20, 32, 79, 100, 114, 171,
196, 199, 201, 203, 208, 210, 227
Semi- solid, 10, 30, 54, 68, 69, 72, 78, 79, 88, 91,
97, 100, 113, 136, 218
Shrinkage, 108, 113
Signicance, 25, 95, 122, 136, 211, 215
Silicon, 105, 112, 128
Sintering, 10, 13, 23, 27, 33– 35, 55, 104, 110,
113, 114, 123, 129, 130, 138, 139, 142,
145– 150, 154, 181, 227, 228
SLA, 7, 8, 10, 14, 31, 34, 35, 64, 108, 135– 137,
139, 141– 147, 149, 150, 154, 157, 167, 168,
228
SLS, 10, 13, 14, 27, 34, 35, 42, 68, 133, 135– 139,
141– 149, 154, 156, 157, 227
Sodium, 12– 14, 16, 73, 91, 105, 106, 112, 118,
128, 132, 141, 160, 165, 168
Solidication, 55, 83, 95, 123, 137, 138, 142, 149
Solubility, 54, 55, 110, 136, 147, 160
Solvent, 9, 10, 68, 84, 87, 91, 104
Sophisticated, 40, 82, 125, 164, 200, 202
Spectroscopy, 15, 60, 196, 201, 202, 204, 208– 210
SSE, 13, 68, 69, 71– 74, 77, 78, 87, 90, 136, 141
Stability, 18, 40, 52, 53, 55– 59, 77, 90, 92, 109,
110, 129, 142, 145, 156– 160, 164, 186, 200,
212, 219, 220
Standards, 40– 42, 52, 56– 61, 87, 93, 164, 180,
183, 186, 197, 199, 200, 203, 204, 207,
212– 214, 220– 223
Stereolithography, 7, 26, 31, 32, 34, 45, 64, 68,
137, 139, 146, 148, 149, 154, 172, 181
Strength, 12, 13, 15, 31, 60, 84, 86, 92, 104, 106,
107, 109– 113, 117, 119, 124, 141, 142, 148,
159, 162, 164, 166, 167, 181, 196, 199– 201,
210, 212
Stress, 84, 91, 96, 103, 104, 122, 136, 142, 167, 200
Structural, 4, 40, 57, 59, 60, 72, 91, 92, 97, 122,
159, 162, 173, 200
Surgical, 4– 6, 18– 20, 67, 72, 78, 93– 95, 156, 164,
166, 219
Sustainable, 9, 40, 43, 45, 140, 170, 185, 186,
189– 191, 193, 194
Systematic, 44, 96, 110, 191, 192, 197, 208, 209,
211, 220
Index
https://t.me/med1917
233
Index
T
Tablet, 8, 11, 12, 14– 17, 23, 37, 39, 67, 72, 74, 75,
80, 88, 89, 103– 106, 112, 116, 127, 130, 141,
143, 146, 165, 199– 201, 205, 208, 218
Technique, 3, 6, 9, 10, 16– 19, 23, 26, 29– 31, 33,
34, 36, 37, 40, 68, 79, 82– 84, 87– 92, 94, 108,
114, 115, 120, 123, 125, 126, 132, 135, 137,
139, 141– 143, 150, 160, 165, 167, 174, 196,
200, 201, 203, 206, 207, 227, 228
Technological, 9, 51, 59, 60, 118, 186, 191, 193,
194, 206, 220
Temperature, 12, 14, 30, 33, 54, 55, 57, 59, 60, 68,
69, 71, 77, 84– 86, 90– 92, 95, 97, 103, 104, 107,
113, 123, 136, 138, 139, 145, 155, 168, 170,
174, 196, 200, 201, 203, 208
Tensile, 12, 15, 117, 141, 142, 160, 200, 209, 210
Tension, 71, 104, 106, 109, 122– 124, 199
Therapeutic, 4, 5, 7, 8, 11, 37, 52, 56, 57, 61, 63,
75, 80, 87– 89, 95, 96, 115, 143, 148, 166, 195,
201, 210, 223
Therapy, 3, 6, 8, 10, 19, 38, 61, 81, 89, 95, 116,
132, 136, 145, 165, 170, 218, 222, 228
Thermal, 12, 16, 32, 35, 42, 60, 84, 86, 92, 95,
107, 108, 113, 123, 124, 128, 129, 132, 136,
140, 145, 160, 196, 205, 218, 222, 226
Thickness, 12, 16, 57, 85, 94, 107– 9, 112, 115,
116, 125, 168, 199– 201, 203
Three- dimensional, 3, 20– 24, 26, 32, 44, 45, 63,
64, 81, 94, 103, 104, 112, 115, 120, 129– 132,
135, 142, 144, 146, 149, 172, 175, 195, 208,
209, 227
Tissues, 4, 5, 27, 42, 67, 115, 142, 158, 159, 162,
164, 171, 174
Tomography, 4, 199, 201, 209, 210
Tool, 4, 21, 24, 47, 54, 63, 79, 117, 118, 140, 154,
202, 210, 211, 218
Toughness, 95, 159, 163
Transformative, 42, 52, 58, 60, 94
Transportation, 4, 184– 186, 188, 189
Treatment, 3– 8, 11, 19, 23, 33, 37– 39, 43, 52,
61– 63, 72– 74, 78, 80, 88, 96, 106, 136,
164, 165, 182, 184, 189, 191, 194, 216,
226
U
Utilization, 8– 11, 96, 146, 211
V
Validation, 41, 52, 53, 56– 58, 60, 180, 195,
225
Value, 18, 43, 44, 129, 174, 185, 186, 226
Variables, 57, 59, 90, 92, 95, 107, 108, 121, 124,
125, 136, 145, 201, 228
Variation, 14, 15, 113, 159
Variety, 5, 10, 30, 34, 42, 43, 54, 55, 68, 72, 74,
75, 82, 87, 121, 135, 138, 139, 159, 164, 184,
187, 202
Vascular, 72, 78, 89, 158, 173, 191, 218
Versatile, 34, 78, 83, 84, 103, 128, 143, 156, 157,
159, 160, 211, 213
Viscosity, 15, 16, 70– 72, 77, 78, 82, 84, 91, 92,
106, 109, 122– 124, 158
233
Соседние файлы в папке Библиотека им академика М.И. Перельмана